0
0
The World Health Organization (WHO) and partners have launched a roadmap to stop by 2030, bacterial meningitis outbreaks on the continent
With the COVID-19 pandemic delaying meningitis vaccination campaigns for more than 50 million children in Africa, the region is at a heightened risk of outbreaks of meningitis type A, the UN health agency said on Thursday.
The World Health Organization (WHO) and partners have launched a roadmap to stop by 2030, bacterial meningitis outbreaks on the continent.
In a race against time, African countries are being urged to rapidly implement the plan before the start of the meningitis season in January, which runs until June.
“More than 400 million Africans are still at risk of seasonal meningitis outbreaks, but the disease has remained off the radar for too long,” said Matshidiso Moeti, WHO Regional Director for Africa
Meningitis is caused by inflammation of the membranes surrounding the brain and spinal cord. Acute bacterial meningitis can cause death within 24 hours and leaves one in five survivors with lifelong disability.
African success story
Historically, type A was the highest meningitis outbreak in Africa.
However, in 2010 the effective MenAfriVac vaccine was developed and deployed throughout the continent.
With WHO and partners’ support, more than 350 million people in 24 high-risk African countries have to date, received the MenAfriVac vaccine.
While meningitis type A accounted for 90 per cent of cases and deaths before 2010, no new cases have been reported since 2017.
Controlling that lethal form of meningitis has led to fewer meningitis type A deaths and while half of meningitis-affected people died in 2004, in 2021, 95 per cent of cases survived.
More than 400 million Africans are still at risk of seasonal meningitis outbreaks, but the disease has remained off the radar for too long
“The defeat of meningitis type A is of one of Africa’s biggest success stories in health, but the fallout from COVID-19Opens in new window hampers our drive to eliminate this bacterial infection as a public health threat once and for all, and could lead to catastrophic resurgences,” said Dr. Moeti.
Trending backwards
The pandemic severely disrupted meningitis prevention and control services, with disease surveillance, laboratory confirmation of cases and outbreak investigations all steeply declining.
Based on country reports, WHO found that meningitis control activities were reduced by 50 per cent in 2020 compared with 2019, with a slight improvement in last year.
While no meningitis type A case has been reported in Africa over the past five years, outbreaks still occur and are caused by other types of meningococcal bacteria.
In 2019, 140,552 Africans died from all types of meningitis, with major outbreaks of meningitis type C recorded in seven so-called “meningitis belt countries” since 2013.
And last year, a four-month outbreak in the Democratic Republic of the Congo claimed 205 lives.
Moreover, Africa is the only region to still experience outbreaks and accounts for the highest number of new meningitis cases globally – reporting 100 cases per 100,000 people.
“Aside from the toll on human life, outbreaks negatively impact health systems, our fragile economies, and impoverish entire populations forced to contend with multiple health and socio-economic challenges,” lamented Dr Moeti.
Fighting back
In an ambitious bid to defeat bacterial meningitis in Africa by 2030, the new regional strategy sets out a roadmap for countries to shore up diagnosis, surveillance, care, advocacy and vaccination to eliminate outbreaks, curb deaths by 70 per cent and halve infections.
WHO estimates that $1.5 billion will be required between now and 2030 to implement the plan, which if fully adopted will save more than 140,000 lives every year in the region and significantly reduce disability.
“In prioritizing the response to COVID-19, we must not lose our focus on other health problems,” underscored the senior WHO official, urging countries to “ramp up implementation of the new WHO regional roadmap now”.
About Author
OTHER ARTICLES
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)